Chemical Formula: C14H16N2O4
Chemical Formula C14H16N2O4
Found 53 metabolite its formula value is C14H16N2O4
N-lactoyl-Tryptophan
(2S)-2-{[(2S)-1,2-dihydroxypropylidene]amino}-3-(1H-indol-3-yl)propanoate
N-lactoyl-Tryptophan is lactoyl derivative of tryptophan. N-lactoyl-amino acids are ubiquitous pseudodipeptides of lactic acid and amino acids that are rapidly formed by reverse proteolysis. A protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation. The plasma levels of these metabolites strongly correlate with plasma levels of lactate and amino acid. (PMID: 25964343)
5-Benzylacyclouridine
5-benzyl-1-[(2-hydroxyethoxy)methyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
D004791 - Enzyme Inhibitors
8-hydroxy-3,7-dimethoxy-1,2,3,11a-tetrahydro-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5-one|Methyl-Neotramizin A|Methyl-Neotramizin B
8-hydroxy-3,7-dimethoxy-1,2,3,11a-tetrahydro-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5-one|Methyl-Neotramizin A|Methyl-Neotramizin B
Taglutimide
2-(2,6-dioxo-piperidin-3-yl)-hexahydro-4,7-methano-isoindole-1,3-dione
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Oxagrelate
6-Phthalazinecarboxylicacid, 3,4-dihydro-1-(hydroxymethyl)-5,7-dimethyl-4-oxo-, ethyl ester
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
1-(tert-Butoxycarbonyl)-5-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
1-(tert-Butoxycarbonyl)-5-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
1-TERT-BUTYL 5-METHYL 1H-INDAZOLE-1,5-DICARBOXYLATE
1-TERT-BUTYL 5-METHYL 1H-INDAZOLE-1,5-DICARBOXYLATE
[(2S)-1-(4-nitrophenyl)pyrrolidin-2-yl]methyl prop-2-enoate
[(2S)-1-(4-nitrophenyl)pyrrolidin-2-yl]methyl prop-2-enoate
5-ethyl-1-(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
5-ethyl-1-(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
ETHYL 4-(2-HYDROXYPHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE
ETHYL 4-(2-HYDROXYPHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE
Ethyl 4-hydroxy-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate
Ethyl 4-hydroxy-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate
5-[(2-methylpropan-2-yl)oxycarbonylamino]-1H-indole-2-carboxylic acid
5-[(2-methylpropan-2-yl)oxycarbonylamino]-1H-indole-2-carboxylic acid
methyl 2-tert-butyl-5-nitro-1H-indole-7-carboxylate
methyl 2-tert-butyl-5-nitro-1H-indole-7-carboxylate
2-acetamido-3-(6-Methoxy-1H-indol-3-yl)propanoic acid
2-acetamido-3-(6-Methoxy-1H-indol-3-yl)propanoic acid
Tert-butyl 2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetate
Tert-butyl 2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetate
Y-26763
N-[(3S,4R)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-YL]-N-hydroxyacetamide
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
1,3-diisocyanato-2-methyl-benzene, 2-methyloxirane, oxirane
1,3-diisocyanato-2-methyl-benzene, 2-methyloxirane, oxirane
5-(3-(1-Methylcyclopropyl)propyl)-1H-pyrano(2,3-d)pyrimidine-2,4,7(3H)-trione
5-(3-(1-Methylcyclopropyl)propyl)-1H-pyrano(2,3-d)pyrimidine-2,4,7(3H)-trione
(S)-2-((S)-2-Hydroxypropanamido)-3-(1H-indol-3-yl)propanoic acid
(S)-2-((S)-2-Hydroxypropanamido)-3-(1H-indol-3-yl)propanoic acid
(5R,6R,7S,8S)-5-(Hydroxymethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyridine-6,7,8-triol
(5R,6R,7S,8S)-5-(Hydroxymethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyridine-6,7,8-triol
5-methyl-3-(2-morpholino-2-oxoethyl)-1,3-benzoxazol-2(3H)-one
5-methyl-3-(2-morpholino-2-oxoethyl)-1,3-benzoxazol-2(3H)-one
N-(2-methoxyethyl)-5-(3-methoxyphenyl)-1,2-oxazole-3-carboxamide
N-(2-methoxyethyl)-5-(3-methoxyphenyl)-1,2-oxazole-3-carboxamide
Ethyl 1,2,7-trimethyl-4-nitro-1H-indole-3-carboxylate
Ethyl 1,2,7-trimethyl-4-nitro-1H-indole-3-carboxylate
carboxylato-PTIO
carboxylato-PTIO
A benzoate that is the conjugate base of carboxy-PTIO, obtained by deprotonation of the carboxy group.
(3s,7r,8ar)-1,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(3s,7r,8ar)-1,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
3-{[2-(5-hydroxy-1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}propanoic acid
3-{[2-(5-hydroxy-1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}propanoic acid
(3s,7r,8as)-1,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(3s,7r,8as)-1,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(3s,8as)-3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(3s,8as)-3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
1,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
1,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(8as)-3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(8as)-3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
3-[(3,4-dihydroxyphenyl)methyl]-1-hydroxy-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
4-(4-HO-PH)-6-ME-2-Oxo-1,2,3,4-4H-pyrimidine-5-carboxylic acid ethyl ester
ethyl 4-(4-hydroxyphenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate
1-[2-(3,4-dimethoxyphenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]ethanone
1-[2-(3,4-dimethoxyphenyl)-3-hydroxy-5-methylimidazol-4-yl]ethanone
